Stock INNO INNOCAN PHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 12:16:48 2024-12-10 pm EST 		5-day change 1st Jan Change
0.2200 CAD 0.00% Intraday chart for InnoCan Pharma Corporation +2.33% -29.03%
Nov. 26 InnoCan Pharma Releases Encouraging Results from Study of LPT-CBD on Minipigs MT
Nov. 26 Innocan Pharma Corporation Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs CI

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
InnoCan Pharma Releases Encouraging Results from Study of LPT-CBD on Minipigs
Nov. 26
 MT
Innocan Pharma Corporation Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs
Nov. 26
 CI
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs
Nov. 26
 AQ
InnoCan Pharma : MD&A Report for Three & Nine month period ended September 30, 2024
Nov. 21
 PU
InnoCan Pharma : Financial Statements as of September 30, 2024
Nov. 21
 PU
InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Nov. 20
 CI
InnoCan Pharma Swings to a Q3 Profit on Revenue Gains
Nov. 20
 MT
Innocan Pharma Reports Third Quarter 2024 Financial Results
Nov. 20
 AQ
Innocan Pharma to Present at the 2024 ThinkEquity Conference
Oct. 21
 AQ
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience
Oct. 16
 AQ
Innocan Pharma's LPT-CBD Shows Success in Relieving Osteoarthritis Pain in Dogs
Oct. 11
 MT
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs
Oct. 11
 AQ
Innocan Pharma Corporation's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs
Oct. 11
 CI
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide
Oct. 09
 AQ
Innocan Says FDA "Positive" on it Liposomal Technology-CBD Drug
Sep. 03
 MT
Innocan Pharma Corporation Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting
Sep. 03
 CI
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting
Sep. 03
 AQ
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
Aug. 29
 AQ
InnoCan Pharma Corporation announced that it has received CAD 1.10566 million in funding
Aug. 28
 CI
Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration
Aug. 22
 AQ
InnoCan Pharma Corporation announced that it expects to receive CAD 0.88 million in funding
Aug. 21
 CI
InnoCan Pharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Aug. 12
 CI
Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million
Aug. 12
 AQ
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Jul. 29
 AQ
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Jul. 26
 MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INNO Stock
  4. News InnoCan Pharma Corporation